Can Pharmaceuticals ETF Dodge the Bug? | ETF Trends

The health care sector’s decent performance – relative to other sectors – this month helped give the PowerShares Dynamic Pharmaceuticals (PJP) exchange traded fund (ETF) a shot in the arm.

The sector, overall, has been slightly down this month, but it’s outperforming the other 11 sectors tracked by Morningstar, reports Don Dion for Seeking Alpha. PJP has been boosted by a small rally in pharmaceutical stocks.

The fund has a lot of challenges facing it, though. Can it surmount them? Bad news from some of the fund’s holdings and dull performance results from others could hold it back. So far this month, it has lost 3.5%. What will the future hold?

Z_6

The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any product.